Ascendis Health lists on A2X
The multinational health and care brands company is the first healthcare company to list on the new exchange.
Ascendis Health has become the first healthcare company to list on A2X Markets. It will retain its primary listing on the JSE and its issued share capital will be unaffected by this secondary listing on A2X.
Thomas Thomsen, Ascendis Health CEO, said:
“We are pleased to complement our primary listing on the JSE with the secondary listing on A2X. We see the secondary listing as an opportunity to attract potential new investors through the lower-cost trading structure of A2X and broaden our shareholder base. There is no cost to the secondary listing or any additional regulatory compliance.”
Ascendis Health is a South African-based company with a portfolio of market leading brands and products exported to over 120 countries globally. It has a market cap of R5.4 billion.
Kevin Brady (pictured), A2X CEO, said:
“We are delighted to welcome Ascendis Health aboard. The first healthcare company listing is an important milestone for A2X as we continue to attract listed companies from across various sectors. We look forward to demonstrating the benefits that effective competition in the secondary share market will bring to Ascendis’ investors.”